CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-604-6331440
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees18
Next Earnings Date3/4/2019 (Estimated)
OptionableNot Optionable
CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions
What is CRH Medical's stock symbol?
CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."
How were CRH Medical's earnings last quarter?
CRH Medical Corp (NYSEAMERICAN:CRHM) issued its quarterly earnings data on Wednesday, August, 1st. The company reported $0.02 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.01 by $0.01. The company earned $27.33 million during the quarter, compared to analysts' expectations of $25.70 million. View CRH Medical's Earnings History.
When is CRH Medical's next earnings date?
What is the consensus analysts' recommendation for CRH Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CRH Medical.
Has CRH Medical been receiving favorable news coverage?
Press coverage about CRHM stock has been trending positive on Friday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. CRH Medical earned a coverage optimism score of 2.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an effect on the stock's share price in the next several days.
Who are some of CRH Medical's key competitors?
Some companies that are related to CRH Medical include TransEnterix (TRXC), CRH Medical (CRH), Clover (CLV), Bovie Medical (BVX), Bovie Medical (BVX), SDI (SDI), InfuSystem (INFU), Daxor (DXR), TSO3 (TOS), IsoRay (ISR), Retractable Technologies (RVP), IsoRay (ISR), Milestone Scientific (MLSS), Relevium Technologies (RLV) and Impression Healthcare (IHL).
What other stocks do shareholders of CRH Medical own?
Who are CRH Medical's key executives?
CRH Medical's management team includes the folowing people:
- Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
- Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
- Mr. James Kreger, Pres of CRH Anesthesia Management
- Ms. Kettina Cordero, Director of Investor Relations
- Dr. Mitchel Guttenplan M.D., FACS, Medical Director
Who are CRH Medical's major shareholders?
CRH Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (9.09%), Beutel Goodman & Co Ltd. (7.12%), Connor Clark & Lunn Investment Management Ltd. (3.06%), Canada Pension Plan Investment Board (1.17%), Mackenzie Financial Corp (0.64%) and D. E. Shaw & Co. Inc. (0.45%).
Which major investors are selling CRH Medical stock?
CRHM stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, D. E. Shaw & Co. Inc., ClariVest Asset Management LLC and TD Asset Management Inc..
Which major investors are buying CRH Medical stock?
CRHM stock was bought by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Connor Clark & Lunn Investment Management Ltd., Nantahala Capital Management LLC, Canada Pension Plan Investment Board, Beutel Goodman & Co Ltd., Acadian Asset Management LLC and Two Sigma Advisers LP.
How do I buy shares of CRH Medical?
Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CRH Medical's stock price today?
One share of CRHM stock can currently be purchased for approximately $3.29.
How big of a company is CRH Medical?
CRH Medical has a market capitalization of $236.57 million. CRH Medical employs 18 workers across the globe.
What is CRH Medical's official website?
How can I contact CRH Medical?
CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.
MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRHM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.
